IntegriChain Hosts Revenue Analytics Collaborative Summit

Policy, Pricing, and Reimbursement Expert Jeff Baab to Keynote
on Industry's Significant Pressures

Executive Fireside Chat on Industry Risk Features Kristen Landon, CCO, 60 Degrees
 Pharmaceuticals

12 Roundtable Discussions Include the IRA, Medicare Part D Redesign, 340B, and
Strategic Net Revenue Modeling

PHILADELPHIA, March 5, 2025 /PRNewswire/ -- IntegriChain, the leading provider of pharma revenue optimization technology and insights, will host the annual RAC Summit, March 27, 2025, in East Brunswick, NJ, sponsored by the Revenue Analytics Collaborative (RAC). The RAC Summit is free to Pharmaceutical manufacturers who wish to learn more about industry challenges and regulations related to pricing and reimbursement, ask questions about commercialization and net revenue optimization, and share best practices amongst industry colleagues. Jeff Baab, an IntegriChain Partner in the Consulting and Advisory practice, will keynote the event and explore significant policy, pricing, and reimbursement pressures that Pharmaceutical professionals face. The event also includes a fireside chat with a voice of the industry featuring Kristen Landon, CCO of 60 Degrees Pharmaceuticals who shares expertise from a 25+-year career; insightful roundtable discussions; and industry networking opportunities.

"The RAC Summit is a can't-miss event for any Pharma/Biotech business or finance professional in Market Access, Contracts & Pricing, or Finance and Accounting focused on Government, Commercial, and Gross-to-Net strategy, management, and optimization," said Jen Sharpe, RAC facilitator and Vice President in IntegriChain's Consulting and Advisory practice. "The collective power of an industry-peer group like the RAC is unmatched, and this event brings together the best of the best to share with those of like experience as well as those newer to the industry. The positive spirit of the event is simply unparalleled, and the insights delivered are tremendously valuable to all participants."

The RAC Summit's Roundtable Discussions will include the following pressing topics.

• Policy Impact Discussion: Current Administration Priorities, Latest on the IRA & Pricing Considerations
  
  
• Medicare Part D Redesign: Manufacturer Discount Program Implications
  
  
• GTN Monthly Close Excellence: Best Practices & Methodologies
  
  
• All Things 340B: Latest Developments, Risks vs. Opportunities & Revenue Leakage
  
  
• Impact of Patient Support Programs & Innovative Channel Design on GTN: From Copay Programs to Digital Pharmacies
  
  
• Payer & Provider Economics: Payer Deal Analytics, ASP / Provider Cost Recovery and Evolving Payer Contracting Implications
  
  
• Payer and Medicaid Intelligence: Medicaid Budget Cuts, State Data Trends, Invoice Analysis & Rebate Strategy Insights
  
  
• Beyond GTN Forecasting: Strategic Net Revenue Modeling Approaches
  
  
• Demand & Inventory Management: Aligning Pipeline with Sales and Market Demand
  
  
• Product Launch Excellence: Integrated Government, Commercial & GTN Launch Strategies
  
  
• Returns & Inventory Management: Pipeline Data Vendors, Methodologies & DSCSA/Serialization Updates
  
  
• State Price Transparency: Compliance Success Stories & Key States to Watch

About the Revenue Analytics Collaborative
The RAC is a private, industry peer networking and benchmarking group with more than 850 industry colleagues from more than 275 manufacturers, sponsored by IntegriChain. Members include business and financial professionals who own, support, and analyze Commercial, Government, Gross-to-Net (GTN), and Trade/Channel data, processes, and systems in Pharmaceutical companies large and small. The RAC offers members benchmarking, workshops, webinars, and lunch-and-learns, confidential advice and guidance, discussion boards, and industry networking. Interested professionals can learn more here: RACollab.org.

About IntegriChain
IntegriChain is the leading provider of revenue optimization technology and insights for the Pharma industry. The company's unique combination of data management, enterprise applications, consulting, and outsourcing helps manufacturers achieve better financial results by connecting commercial execution to net revenue. IntegriChain is backed by Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in Healthcare and Technology. IntegriChain's umbrella of companies include Blue Fin Group and Federal Compliance Solutions, and the company is headquartered in Philadelphia, PA, with offices in Ambler, PA, and Pune, India. For more information, visit www.integrichain.com or follow on LinkedIn.

Contact
Jennifer Guinan, Sage Strategic Marketing, [email protected]

SOURCE IntegriChain